Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females
- PMID: 7494114
- DOI: 10.1017/s0022215100131445
Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females
Abstract
Type 2 neurofibromatosis is a dominantly inherited disorder in which the great majority of sufferers develop bilateral vestibular schwannomas. In a UK study of 183 individuals from 112 families we have previously shown a fairly similar disease course within families, but quite marked inter-familial variation. We have confirmed an increase in severity when the gene is inherited from an affected mother, but evidence that women are more severely affected than men is lacking. Age at onset of symptoms, of deafness and at diagnosis are identical for the entire dataset and for a comparison of 10 male/female sibling pairs. Only three out of 42 pregnancies in symptomatic women were accompanied by a reversible worsening in symptoms due to vestibular schwannomas. Of 328 consecutive cases of unilateral vestibular schwannoma, there was no significant difference in the sex ratio or size. There now appears to be little evidence for a female hormonal effect on vestibular schwannomas. However, females with type 2 neurofibromatosis have significantly more meningiomas.
Similar articles
-
Neurofibromatosis type 2.Otolaryngol Clin North Am. 2015 Jun;48(3):443-60. doi: 10.1016/j.otc.2015.02.005. Otolaryngol Clin North Am. 2015. PMID: 26043141 Review.
-
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.J Med Genet. 2011 Apr;48(4):261-5. doi: 10.1136/jmg.2010.085241. Epub 2011 Jan 28. J Med Genet. 2011. PMID: 21278391
-
Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.Hum Mol Genet. 1994 Feb;3(2):347-50. doi: 10.1093/hmg/3.2.347. Hum Mol Genet. 1994. PMID: 8004107
-
Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.J Neurosurg. 2012 Jul;117(1):109-17. doi: 10.3171/2012.3.JNS111649. Epub 2012 Apr 13. J Neurosurg. 2012. PMID: 22503123 Free PMC article.
-
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.Curr Oncol Rep. 2023 May;25(5):531-537. doi: 10.1007/s11912-023-01388-3. Epub 2023 Mar 18. Curr Oncol Rep. 2023. PMID: 36933171 Review.
Cited by
-
Neurofibromatosis type 2.J Med Genet. 2000 Dec;37(12):897-904. doi: 10.1136/jmg.37.12.897. J Med Genet. 2000. PMID: 11106352 Free PMC article. Review.
-
Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.J Med Genet. 2003 Nov;40(11):802-6. doi: 10.1136/jmg.40.11.802. J Med Genet. 2003. PMID: 14627667 Free PMC article.
-
Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma.J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):764-7. doi: 10.1136/jnnp.66.6.764. J Neurol Neurosurg Psychiatry. 1999. PMID: 10329751 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Research Materials